Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients
- PMID: 28380430
- PMCID: PMC5464844
- DOI: 10.18632/oncotarget.16518
Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients
Abstract
Due to heterogeneous multifocal nature of prostate cancer (PCa), there is currently a lack of biomarkers that stably distinguish it from benign prostatic hyperplasia (BPH), predict clinical outcome and guide the choice of optimal treatment. In this study RNA-seq analysis was applied to formalin-fixed paraffin-embedded (FFPE) tumor and matched normal tissue samples collected from Russian patients with PCa and BPH. We identified 3384 genes differentially expressed (DE) (FDR < 0.05) between tumor tissue of PCa patients and adjacent normal tissue as well as both tissue types from BPH patients. Overexpression of four of the discovered genes (ANKRD34B, NEK5, KCNG3, and PTPRT) was validated by RT-qPCR. Furthermore, the enrichment analysis of overrepresented microRNA and transcription factor (TF) recognition sites within DE genes revealed common regulatory elements of which 13 microRNAs and 53 TFs were thus linked to PCa for the first time. Moreover, 8 of these TFs (FOXJ2, GATA6, NFE2L1, NFIL3, PRRX2, TEF, EBF2 and ZBTB18) were found to be differentially expressed in this study making them not only candidate biomarkers of prostate cancer but also potential therapeutic targets.
Keywords: FFPE; RNA biomarkers; RNA-Seq; benign prostatic hyperplasia; prostate cancer.
Conflict of interest statement
The authors declare no conflicts of interests.
Figures
Similar articles
-
Proteomic analysis of formalin-fixed prostate cancer tissue.Mol Cell Proteomics. 2005 Nov;4(11):1741-53. doi: 10.1074/mcp.M500102-MCP200. Epub 2005 Aug 9. Mol Cell Proteomics. 2005. PMID: 16091476
-
Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.Lipids Health Dis. 2023 Mar 14;22(1):39. doi: 10.1186/s12944-023-01804-4. Lipids Health Dis. 2023. PMID: 36915125 Free PMC article.
-
mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials.Exp Mol Pathol. 2010 Feb;88(1):45-51. doi: 10.1016/j.yexmp.2009.10.005. Epub 2009 Oct 27. Exp Mol Pathol. 2010. PMID: 19874819 Free PMC article.
-
Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Biomed Res Int. 2013;2013:283635. doi: 10.1155/2013/283635. Epub 2013 Nov 25. Biomed Res Int. 2013. PMID: 24371818 Free PMC article. Review.
-
Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.Asian J Androl. 2012 May;14(3):385-92. doi: 10.1038/aja.2011.147. Epub 2012 Feb 6. Asian J Androl. 2012. PMID: 22306912 Free PMC article. Review.
Cited by
-
Identification of a Transcriptomic Prognostic Signature by Machine Learning Using a Combination of Small Cohorts of Prostate Cancer.Front Genet. 2020 Nov 25;11:550894. doi: 10.3389/fgene.2020.550894. eCollection 2020. Front Genet. 2020. PMID: 33324443 Free PMC article.
-
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.Elife. 2020 Jul 20;9:e54166. doi: 10.7554/eLife.54166. Elife. 2020. PMID: 32686647 Free PMC article.
-
Niraparib restrains prostate cancer cell proliferation and metastasis and tumor growth in mice by regulating the lncRNA MEG3/miR-181-5p/GATA6 pathway.PeerJ. 2023 Nov 29;11:e16314. doi: 10.7717/peerj.16314. eCollection 2023. PeerJ. 2023. PMID: 38047026 Free PMC article.
-
Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.BMC Cancer. 2020 Jan 6;20(1):23. doi: 10.1186/s12885-019-6408-4. BMC Cancer. 2020. PMID: 31906878 Free PMC article.
-
Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer.Front Genet. 2022 Mar 16;13:798170. doi: 10.3389/fgene.2022.798170. eCollection 2022. Front Genet. 2022. PMID: 35368696 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso CS, Kominsky HD, Cao X, Jing X, Wang X, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;29:742–9. - PMC - PubMed
-
- Ylipää A, Kivinummi K, Kohvakka A, Annala M, Latonen L, Scaravilli M, Kartasalo K, Leppänen SP, Karakurt S, Seppäla J, Yli-Harja O, Tammela TLJ, Zhang W, et al. Transcriptome sequencing reveals PCAT5 as a Novel ERG-Regulated long Noncoding RNA in prostate cancer. Cancer Res. 2015;75:4026–31. - PubMed
-
- Petryszak R, Keays M, Tang YA, Fonseca NA, Barrera E, Burdett T, Füllgrabe A, Fuentes AMP, Jupp S, Koskinen S, Mannion O, Huerta L, Megy K, et al. Expression Atlas update—an integrated database of gene and protein expression in humans, animals and plants. Nucleic Acids Res. 2016;44:D746–52. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
